Woodstock (OTCMKTS: WSFL) is a development-stage company focused on the production, marketing and distribution of hemp-derived cannabidiol (CBD) products and related botanical wellness solutions. Since its inception in 2015, the company has built a vertically integrated platform encompassing cultivation, extraction and finished-goods manufacturing. Woodstock’s product portfolio includes tinctures, softgels, topicals and nutraceutical supplements designed for both direct-to-consumer sales and business-to-business white-label partnerships.
The company operates a Good Manufacturing Practice (GMP)–certified facility in Denver, Colorado, where it oversees critical stages of the production process, from seed selection and greenhouse propagation to supercritical CO₂ extraction and third-party quality testing. In addition to its in-house brands, Woodstock offers contract manufacturing services, leveraging its expertise in formulation science and regulatory compliance to support emerging consumer packaged goods companies in the health and wellness space.
Woodstock’s commercial footprint extends across the United States through partnerships with regional distributors, health-and-wellness retailers and e-commerce platforms. The company maintains strategic supply-chain relationships to secure high-quality hemp biomass and packaging components, while also exploring opportunities in select international markets where regulatory frameworks permit the importation of hemp-derived products.
Under the guidance of a management team with extensive experience in consumer goods, botanical extraction and pharmaceutical quality systems, Woodstock continues to invest in research and development aimed at expanding its product pipeline. The company’s leadership is committed to advancing sustainable cultivation practices and enhancing manufacturing efficiencies as it works to solidify its position in the rapidly evolving CBD and natural-wellness industries.
AI Generated. May Contain Errors.
